世界の血管閉鎖デバイス市場は2021年の9億ドルから2026年までに13億ドルに達し、予測期間中のCAGRは7.0％と予想されます。この市場の成長を促す要因としては、多くの血管閉鎖装置の承認、心血管疾患の高い有病率、肥満の有病率の増加、大口径血管閉鎖装置への市場プレーヤーの注目の高まり、高齢者人口の増加、インターベンショナルラジオロジーに関する有利な保険適応シナリオ、手術中の患者の効果的な失血管理への注目の高まり、などが挙げられます。 市場プレーヤーに成長機会を与えている新興市場と病院および手術センターの増加は、市場のプレーヤーに強力な成長機会をもたらすことが期待されています。一方で、高度なスキルを持つ専門家の必要性、血管閉鎖装置に関連するリスク、および厳しい規制の枠組みが、ある程度市場の成長を妨げる可能性があります。血管閉鎖装置市場は、種類別、アクセス別、処置別、および地域別に分類されます。
COVID-19の発生による全国的な封鎖、創傷治療サービスの拒否、および選択的手術のキャンセルまたは延期によって、2020年の血管閉鎖装置市場はマイナスの影響を受けました。利用可能な限られた能力と資源（ベッドや患者ケアの専門家など）をCOVID-19患者ケアに予約または振り向けるために、待機的手術が拒否（キャンセル/延期）されていました。さらに、COVID-19の感染拡大を抑えるために、さまざまな国がロックダウンと夜間外出禁止令を発出しました。これらのロックダウンのため、患者は病院や外来、クリニックなどで受診することができませんでした。非緊急医療サービスの一時的な拒否は、血管閉鎖装置市場の成長を抑制すると予想されます。ただし、血管閉鎖装置の需要は今後増加すると予想されます。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 24)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
FIGURE 1 VASCULAR CLOSURE DEVICES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 27)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.6 MARKET SHARE ANALYSIS
2.7 ASSUMPTIONS FOR THE STUDY
2.7.1 COVID-19-SPECIFIC ASSUMPTIONS
2.8 LIMITATIONS
2.9 RISK ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 43)
FIGURE 11 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021 VS. 2026 (USD MILLION)
FIGURE 13 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 46)
4.1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW
FIGURE 15 LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH
4.2 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021-2026)
FIGURE 16 PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 17 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 2020
4.4 VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
FIGURE 19 VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing approvals of vascular closure devices
TABLE 1 APPROVALS OF VASCULAR CLOSURE DEVICES
5.2.1.2 High prevalence of cardiovascular diseases
5.2.1.3 Increasing prevalence of obesity
5.2.1.4 Increasing focus of market players on large-bore vascular closure devices
5.2.1.5 Growing geriatric population
5.2.1.6 Favorable reimbursement scenario for interventional radiology procedures
TABLE 2 REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US
5.2.1.7 Rising focus on effective blood loss management in patients during surgeries
5.2.1.8 Increasing investments, funds, and grants for research on vascular devices
5.2.2 RESTRAINTS
5.2.2.1 Increasing preference for interventional procedures using radial artery access
5.2.2.2 High cost of vascular closure devices
5.2.2.3 Product recalls and failures
TABLE 3 RECENT RECALLS OF VASCULAR CLOSURE DEVICES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets providing growth opportunities for market players
5.2.3.2 Growth in the number of hospitals & surgical centers
5.2.4 CHALLENGES
5.2.4.1 Need for highly skilled professionals
5.2.4.2 Risks associated with vascular closure devices
5.2.4.3 Stringent regulatory frameworks
5.3 COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET
6 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (Page No. - 60)
6.1 INTRODUCTION
TABLE 4 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 5 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
6.2 PASSIVE APPROXIMATORS
TABLE 6 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 7 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 8 PASSIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 9 PASSIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.1 COLLAGEN PLUGS
6.2.1.1 Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period
TABLE 10 COLLAGEN PLUGS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 11 COLLAGEN PLUGS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.2 SEALANT OR GEL-BASED DEVICES
6.2.2.1 Sealant or gel-based devices to register the highest growth rate during the forecast period
TABLE 12 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 13 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.3 COMPRESSION ASSIST DEVICES
6.2.3.1 Compression assist devices do not leave behind any foreign body in the tissue artery—a major advantage of these devices
TABLE 14 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 15 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3 ACTIVE APPROXIMATORS
TABLE 16 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 17 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 18 ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 19 ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.1 SUTURE-BASED DEVICES
6.3.1.1 Increasing applications of suture-based devices to favor market growth
TABLE 20 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 21 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.2 CLIP-BASED DEVICES
6.3.2.1 Growing innovation in the field of clip-based devices to aid market growth
TABLE 22 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 23 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4 EXTERNAL HEMOSTATIC DEVICES
6.4.1 RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH
TABLE 24 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 25 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
7 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS (Page No. - 73)
7.1 INTRODUCTION
TABLE 26 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 27 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
7.2 FEMORAL ACCESS
7.2.1 ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH
TABLE 28 FEMORAL ACCESS: RESEARCH STUDIES
TABLE 29 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 30 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
7.3 RADIAL ACCESS
7.3.1 TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 31 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 32 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
8 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE (Page No. - 79)
8.1 INTRODUCTION
TABLE 33 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 34 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
8.2 INTERVENTIONAL CARDIOLOGY
8.2.1 ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH
TABLE 35 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017-2020 (USD MILLION)
TABLE 36 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021-2026 (USD MILLION)
8.3 INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY
8.3.1 GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES
TABLE 37 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2017-2020 (USD MILLION)
TABLE 38 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2021-2026 (USD MILLION)
9 VASCULAR CLOSURE DEVICES MARKET, BY REGION (Page No. - 85)
9.1 INTRODUCTION
TABLE 39 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 40 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 41 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 42 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 43 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 44 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 45 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 46 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 47 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 48 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 50 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 51 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 52 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American vascular closure devices market
TABLE 53 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
TABLE 54 US: KEY MACROINDICATORS
TABLE 55 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 56 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 57 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 58 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 59 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 60 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 61 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 62 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 63 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 64 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 65 CANADA: KEY MACROINDICATORS
TABLE 66 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 67 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 68 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 69 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 70 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 71 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 72 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 73 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 74 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 75 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.3 EUROPE
TABLE 76 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION, BY COUNTRY, 2018
TABLE 77 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 78 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 79 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 80 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 81 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 82 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 83 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 84 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 85 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 86 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 87 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 88 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.3.1 E-3
9.3.1.1 Increase in number of radial procedures to boost the market demand
TABLE 89 GERMANY: KEY MACROINDICATORS
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 FRANCE: KEY MACROINDICATORS
TABLE 92 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 93 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 94 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 95 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 96 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 97 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 98 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 99 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 100 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 101 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.3.2 REST OF EUROPE
TABLE 102 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 103 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 104 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 105 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 106 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 107 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 108 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 109 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 110 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 111 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 112 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC
FIGURE 21 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
TABLE 113 CHINA: KEY MACROINDICATORS
TABLE 114 JAPAN: KEY MACROINDICATORS
TABLE 115 INDIA: KEY INDICATORS
TABLE 116 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 117 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 119 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 121 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 123 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 125 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH
TABLE 126 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 127 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 128 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 129 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 130 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 131 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 132 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
TABLE 133 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
TABLE 134 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
TABLE 135 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 131)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 136 OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 22 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 23 VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 137 VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 24 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 25 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 138 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
TABLE 139 DEALS
10.7.3 OTHER DEVELOPMENTS
TABLE 140 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 142)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 TERUMO CORPORATION
TABLE 141 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 26 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 142 EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD)
11.1.2 ABBOTT LABORATORIES
TABLE 143 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.3 CARDINAL HEALTH
TABLE 144 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 28 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.4 CARDIVA MEDICAL, INC.
TABLE 145 CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW
11.1.5 MEDTRONIC PLC
TABLE 146 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.6 MORRIS INNOVATIVE, INC.
TABLE 147 MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW
11.1.7 TELEFLEX INCORPORATED
TABLE 148 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
FIGURE 30 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
11.1.8 MERIT MEDICAL SYSTEMS, INC.
TABLE 149 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 31 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
11.1.9 VASORUM LTD.
TABLE 150 VASORUM LTD.: BUSINESS OVERVIEW
11.1.10 TZ MEDICAL, INC.
TABLE 151 TZ MEDICAL INC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 VIVASURE MEDICAL LTD.
11.2.2 TRICOL BIOMEDICAL
11.2.3 SCION BIOMEDICAL
11.2.4 ADVANCED VASCULAR DYNAMICS
11.2.5 MARINE POLYMER TECHNOLOGIES, INC.
11.2.6 TRANSLUMINAL TECHNOLOGIES
11.2.7 REX MEDICAL
11.2.8 MERIL LIFE SCIENCES PVT. LTD.
11.2.9 MEDAS USA
11.2.10 VYGON COMPANY
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 176)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
